www.covidmabs.com
Regeneron is a leading biotechnology company and antibody research pioneer transforming science to medicine for patients with serious diseases. With a robust oncology pipeline of novel classes and combinations, Regeneron is committed to discovering, developing, and delivering innovative therapies to improve the lives of patients with cancer. Learn more at https://www.regeneron.com/pipeline or visit https://ash2020.regeneronmedicalaffairs.com/.
Regeneron is a leading biotechnology company that invents life-transforming medicines for serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and candidates in development. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies. Visit www.Regeneron.com to learn more.